The director of the National Institutes of Health speaks out on his prediction for vaccine approval; Americans are having difficulty finding and trusting coronavirus disease 2019 (COVID-19) information; pandemic-related trends in Alaska are on the rise.
In an interview with NPR, Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), stated he is “guardedly optimistic” about having at least 1 coronavirus disease 2019 (COVID-19) vaccine approved by year-end, possibly late November. The prediction comes despite 2 trials on hold—Johnson & Johnson and Eli Lilly—which he reiterates is a good thing because it means investigators are ensuring vaccine safety. He also warned that with cases of COVID-19 and hospitalizations from the disease on the rise, fatalities are predicted to increase as well. We must continue to wear our masks, social distance, and refrain from indoor social gatherings, he added, because “the virus is not tired of us.”
The AP-NORC Center for Public Affairs Research notes that fewer than 20% of Americans, from a joint online and telephone survey of 1043 adults, trust the news media as their go-to reliable source for all things COVID-19–related, despite using that source daily. They instead prefer to get this information from their health care providers and federal health officials, despite fewer than 25% doing this on a regular basis, 43% having difficulty locating pandemic-related information, and 37% noting greater difficulty tracking down factual, reliable information compared with a few months ago.
Although Alaska’s size, combined with increased opportunities for isolation, worked to its advantage in the summer months of the pandemic, according to The New York Times, now that winter is setting in, case clusters are emerging. Experts, including Anne Zink, MD, Alaska’s chief medical officer, are warning that this early activity in the winter months is a sign of things to come for the entire United States. The state’s once-lauded contract tracing system, too, is now facing difficulty keeping up with the virus’ surge, in that the state that used to be a testing leader is now 1 of 36 “far below the target,” with the average daily positivity rate at 4.25% for the past week.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More